Of all cytokines increased in tumors with high CEP192 expression, IL11, a robust inducer of STAT3 activation, was reported to be increased in HCC tumors and play a critical role in postsurgical recurrence (37). This evidence concerns the gene CEP192 and hepatocellular carcinoma.